Insider trading

Period: 120 months Stock: QTRX Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

167 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

167 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

167 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

167 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
167 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
167 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

167 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 May 2026
Meadows Benjamin Chief Commercial Officer
Bought
$9.70K 3,500 at 2.77
opened
First buy on file
1 Aug 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$6.26K 401 at 15.61
1.1%
5 Jul 2022
HRUSOVSKY E KEVIN Executive Chairman
Sold, plan not stated
$15.91K 960 at 16.57
0.1%
5 Jul 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$6.41K 387 at 16.57
1.0%
2 Jun 2022
HRUSOVSKY E KEVIN Executive Chairman
Sold, plan not stated
$12.44K 712 at 17.47
0.1%
2 Jun 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$6.61K 378 at 17.47
1.0%
2 May 2022
HRUSOVSKY E KEVIN Executive Chairman
Sold, plan not stated 2×
$14.51K 649 at 22.36
0.1%
2 May 2022
Fry John J General Counsel & Secretary
Sold, plan not stated 2×
$9.59K 429 at 22.36
1.1%
1 Apr 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$15.61K 524 at 29.79
1.7%
1 Apr 2022
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated
$7.78K 261 at 29.79
0.7%
1 Apr 2022
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated
$5.09K 171 at 29.79
0.8%
23 Mar 2022
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$97.98K 3,266 at 30.00
5.6%
1 Mar 2022
Fry John J General Counsel & Secretary
Sold, plan not stated 2×
$11.67K 371 at 31.46
1.2%
1 Mar 2022
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 2×
$8.40K 267 at 31.46
0.7%
1 Mar 2022
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated 2×
$5.22K 166 at 31.46
0.7%
9 Feb 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$16.82K 481 at 34.97
1.5%
9 Feb 2022
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated
$11.12K 318 at 34.97
0.8%
9 Feb 2022
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated
$10.21K 292 at 34.97
1.3%
4 Feb 2022
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$100.95K 3,266 at 30.91
5.3%
2 Feb 2022
Fry John J General Counsel & Secretary
Sold, plan not stated 2×
$11.67K 371 at 31.46
1.2%
2 Feb 2022
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 2×
$8.40K 267 at 31.46
0.7%
2 Feb 2022
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated 2×
$5.22K 166 at 31.46
0.7%
31 Jan 2022
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$97.98K 3,266 at 30.00
5.1%
3 Jan 2022
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated
$14.88K 355 at 41.91
0.9%
3 Jan 2022
Fry John J General Counsel & Secretary
Sold, plan not stated
$14.75K 352 at 41.91
1.1%
3 Jan 2022
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated
$6.24K 149 at 41.91
0.6%
29 Dec 2021
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$67.86K 1,667 at 40.71
6.7%
1 Dec 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 2×
$14.22K 353 at 40.29
0.9%
1 Dec 2021
Fry John J General Counsel & Secretary
Sold, plan not stated 2×
$14.10K 350 at 40.29
1.1%
1 Dec 2021
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated 2×
$5.92K 147 at 40.29
0.6%
19 Nov 2021
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$75.92K 1,667 at 45.54
6.3%
5 Nov 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 2×
$488.85K 8,535 at 57.28
18.1%
4 Nov 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated
$57.00 1 at 57.00
0.0%
2 Nov 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 2×
$17.52K 333 at 52.61
0.9%
2 Nov 2021
Fry John J General Counsel & Secretary
Sold, plan not stated 2×
$17.41K 331 at 52.61
1.0%
2 Nov 2021
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated 2×
$7.31K 139 at 52.61
0.6%
15 Oct 2021
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$85.80K 1,667 at 51.47
5.9%
1 Oct 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated
$17.51K 342 at 51.20
0.9%
1 Oct 2021
Fry John J General Counsel & Secretary
Sold, plan not stated
$17.41K 340 at 51.20
1.0%
1 Oct 2021
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated
$7.32K 143 at 51.20
0.6%
22 Sep 2021
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$79.55K 1,667 at 47.72
5.6%
1 Sep 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 2×
$17.62K 353 at 49.92
0.9%
1 Sep 2021
Fry John J General Counsel & Secretary
Sold, plan not stated 2×
$17.47K 350 at 49.92
1.0%
1 Sep 2021
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated 2×
$7.34K 147 at 49.92
0.6%
20 Aug 2021
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$76.90K 1,667 at 46.13
5.3%
3 Aug 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated
$18.61K 346 at 53.79
0.9%
3 Aug 2021
Fry John J General Counsel & Secretary
Sold, plan not stated
$18.50K 344 at 53.79
1.0%
3 Aug 2021
Roskey Mark T. SVP, Strategic Partnerships
Sold, plan not stated
$7.80K 145 at 53.79
0.6%
14 Jul 2021
Duffy David C. SVP R&D and CTO
Sold, plan not stated
$96.30K 1,667 at 57.77
5.0%
2 Jul 2021
Mattoon Dawn Sr. VP, Diagnostics
Sold, plan not stated 3×
$20.26K 347 at 58.38
0.9%
Showing 1–50 of 167. Page 1 of 4 Older →